Podcast explores non-opioid and regenerative approaches to pain relief

In a recent episode of the Denatured podcast, Lance Alstodt, chairman and CEO of BioRestorative Therapies, and Paul Mieyal, chief business officer of South Rampart Pharma, discuss why pain remains a difficult therapeutic area and one of the biggest unmet needs.

The conversation highlights the slow progress in traditional pain treatments and examines emerging strategies that move beyond opioid pathways. Both guests point to non‑opioid mechanisms and regenerative medicine as promising avenues that could change how pain is managed.

They suggest that these innovative approaches may eventually reshape the therapeutic landscape, offering patients alternatives that avoid the risks associated with opioid use.